Primary Hypogonadism-API Insights, 2017
[Report Updated: 30-05-2017]

Published by Delve Insight: 30 May 2017 | 84226
Related Topics: FDA , Hypogonadism

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Primary
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.

India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

DelveInsight’s, Primary Hypogonadism -API Insights, 2017 Report describes the current therapeutics that are propelling the pharmaceutical markets worldwide. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Primary Hypogonadism. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent and patent exclusivity information. The research analysis also presents the global sales data till 2016.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• A snapshot of the global Market therapeutics scenario for Primary Hypogonadism.

• A review of the marketed products under prescription for Primary Hypogonadism, regulatory information and marketing status.

• Coverage of global patent coverage and detailed commentaries on the US patent challenges.

• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

• Product profiles for marketed products for Primary Hypogonadism with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

• Coverage of API Manufacturers for Primary Hypogonadism drugs in the United States, Europe and Asian Regions with location details.

• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Primary Hypogonadism drugs.

• Key discontinued Marketed products.

• Global Sales Figure from 2012-2016.Reasons to Buy

• Evaluate the marketing status and exclusivity details of Primary Hypogonadism key products to exploit opportunities for generic drug development opportunities.

• Key players in the pharmaceutical industry.

•Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.

• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Primary Hypogonadism.

• API intelligence over marketed drugs for Primary Hypogonadism and gaining primary intelligence over active ingredients manufacturers across the globe.

• Uncovering opportunities in the rapidly growing the US markets.

Table of Contents
for Primary Hypogonadism-API Insights, 2017 [Report Updated: 30-05-2017]

List Of Tables
in Primary Hypogonadism-API Insights, 2017 [Report Updated: 30-05-2017]

Primary Hypogonadism Therapeutic Market, US, Marketed Drugs by Application Type, 2017

Primary Hypogonadism Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017

Primary Hypogonadism Therapeutic Market, US, (Year), 2017

Primary Hypogonadism Marketed Drugs, API Manufacturers by US DMF Status, 2017

Primary Hypogonadism Marketed Drugs, US DMF Status Drug Specific (Number), 2017

Primary Hypogonadism Therapeutic Market, Global Sales (in million USD), 2017

Primary Hypogonadism Marketed Drugs, API Manufacturers, Global, 2017

Discontinued Drugs for Primary Hypogonadism, 2017

List Of Figures, Charts and Diagrams
in Primary Hypogonadism-API Insights, 2017 [Report Updated: 30-05-2017]

Primary Hypogonadism Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017

Primary Hypogonadism Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017

Primary Hypogonadism Therapeutic Market, US, (Year), 2017

Primary Hypogonadism Marketed Drugs, API Manufacturers by US DMF Status (%), 2017

Primary Hypogonadism Marketed Drugs, US DMF Status Drug Specific (Number), 2017

Primary Hypogonadism Therapeutic Market, Global Sales (in million USD), 2017

Primary Hypogonadism Marketed Drugs, Patent/Exclusivity Expiry (Year), 2017

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

84226 | DII2017API148

Number of Pages

60

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Primary Health Care Ltd (PRY) - Medical Equipment - Deals and Alliances Profile
SummaryPrimary Health Care Limited (PHC) is a healthcare service provider. The company offers a wide...
28 Jul 2016 by Global Data USD $250 More Info
Primary Health Care Ltd (PRY) - Medical Equipment - Deals and Alliances Profile
SummaryPrimary Health Care Limited (PHC) is a healthcare service provider. The company offers a wide...
14 Apr 2016 by Global Data USD $250 More Info
HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians’ Offices & Clinics) - Global Forecast to 2020
Increasing awareness of cervical cancer screening programs, and government initiative and funding ar...
12 Feb 2016 by MarketsandMarkets USD $4,650 More Info
Medical Equipment Maintenance Market (Remote monitoring & maintenance) by Modality ( Advance, Primary), Type(( Single Vendor OEM, Multi-Vendor OEM), Independent Service Organizations), End-User (Hospitals & Clinics, Diagnostic Center) - Global Forecast to 2020
The global medical equipment maintenance market (remote monitoring & maintenance) is expected to rea...
26 Jan 2016 by MarketsandMarkets USD $4,650 More Info
HIP Reconstruction Devices Market by Product (Primary, Partial, Revision, Hip Resurfacing), and Geography (U.S., Canada, EU-5, Japan, BRIC, Turkey, Indonesia) - Global Forecast to 2020
The global hip reconstruction devices market was valued at USD 4.8 billion in 2014 and is expected t...
26 Jan 2016 by MarketsandMarkets USD $4,650 More Info
Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H2, 2015
Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H2, 2015SummaryGlobalDa...
23 Dec 2015 by Global Data USD $2,500 More Info
Primary Sclerosing Cholangitis Global Clinical Trials Review, H2, 2015
Primary Sclerosing Cholangitis Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical t...
16 Dec 2015 by Global Data USD $2,500 More Info
Primary Biliary Cirrhosis Global Clinical Trials Review, H2, 2015
Primary Biliary Cirrhosis Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial ...
16 Dec 2015 by Global Data USD $2,500 More Info
Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review
Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review provides you an in-dept...
15 Dec 2015 by Global Data USD $125 More Info
Primary Dysmenorrhea Global Clinical Trials Review, H2, 2015
Primary Dysmenorrhea Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial repor...
04 Dec 2015 by Global Data USD $2,500 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)